DCF — SOUTH GEORGIA MEDICAL CENTER
Enterprise Value: $-879.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-879.2M
Enterprise Value
$-272.1M
PV of Cash Flows
$-607.1M
PV of Terminal Value
$-977.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $370.7M | $-58.1M | -16.0% | $-73.8M | $-67.1M |
| Year 2 | $381.8M | $-56.0M | -15.0% | $-72.2M | $-59.6M |
| Year 3 | $393.3M | $-53.7M | -14.0% | $-70.4M | $-52.9M |
| Year 4 | $405.1M | $-53.3M | -13.0% | $-70.5M | $-48.1M |
| Year 5 | $417.3M | $-53.9M | -13.0% | $-71.5M | $-44.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-879.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$359.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16163082838231554
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5